Curis (CRIS) Stock Price, Quote, News & History

Comments

Curis Inc (CRIS) Stock Price, Quote, News & History

CRISNASDAQ

Trade with Public

$1.03

0.044.04%

At close: Mar 9, 5:00 PM EST

$1.01

-0.02-1.94%

After Hours: Mar 6, 7:03 PM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.02

Close

$1.03

Volume / Avg.

77.36K / 494.94K

Day Range

$0.98 - $1.09

52 Wk Range

0.77 - 3.18

Market Cap

$13.06M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

4.54%

Days to Cover

2.33

Recent Curis Inc News

Crude Oil Down 2%; ISM Services PMI Surges In December

Avi Kapoor

US Stocks Edge Higher; UniFirst Shares Fall After Q1 Results

Avi Kapoor

Top 3 Health Care Stocks That May Collapse In Q2

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-30.09M

Investing Cash Flow (TTM)

-428.00K

Financing Cash Flow (TTM)

18.72M

Free Cash Flow (TTM)

-30.09M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-11.80M

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.58M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.95

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-331.66%

Earnings Yield % (FWD)

-255.28%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.07

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$9.05M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.02

Close

$1.03

Volume / Avg.

77.36K / 494.94K

Day Range

$0.98 - $1.09

52 Wk Range

0.77 - 3.18

Market Cap

$13.06M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

4.54%

Days to Cover

2.33

About

Sector

Health Care

Industry

Biotechnology

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hem...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Curis (CRIS) stock?

A

You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Curis (CRIS) competitors?

A

Other companies in Curis’s space includes: Serina Therapeutics Inc (AMEX:SER), Quoin Pharmaceuticals Ltd (NASDAQ:QNRX), Cellectar Biosciences Inc (NASDAQ:CLRB), Imunon Inc (NASDAQ:IMNN) and Longeveron Inc (NASDAQ:LGVN).

Q

What is the forecast, or price target, for Curis (CRIS) stock?

A

Curis has a consensus price target of $15.50.

Q

What is the current price for Curis (CRIS)?

A

The stock price for Curis (NASDAQ: CRIS) is $1.01 last updated March 6, 2026 at 7:03 PM EST.

Q

Does Curis (CRIS) pay a dividend?

A

There are no upcoming dividends for Curis.

Q

When is Curis (NASDAQ:CRIS) reporting earnings?

A

Curis does not have any upcoming earnings scheduled.

Q

Is Curis (CRIS) going to split?

A

There is no upcoming split for Curis.

Q

What sector and industry does Curis (CRIS) operate in?

A

Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

SER

Quoin Pharmaceuticals Ltd

NASDAQ:QNRX

$8.67

2.77%

Cellectar Biosciences Inc

Apimeds Pharmaceuticals Us Inc

LIXT

Key Statistics

Open

$1.02

Close

$1.03

Volume / Avg.

77.36K / 494.94K

Day Range

$0.98 - $1.09

52 Wk Range

0.77 - 3.18

Market Cap

$13.06M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

4.54%

Days to Cover

2.33

Recent Curis Inc News

Crude Oil Down 2%; ISM Services PMI Surges In December

Avi Kapoor

US Stocks Edge Higher; UniFirst Shares Fall After Q1 Results

Avi Kapoor

Top 3 Health Care Stocks That May Collapse In Q2

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-30.09M

Investing Cash Flow (TTM)

-428.00K

Financing Cash Flow (TTM)

18.72M

Free Cash Flow (TTM)

-30.09M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-11.80M

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.58M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.95

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-331.66%

Earnings Yield % (FWD)

-255.28%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.07

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$9.05M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.02

Close

$1.03

Volume / Avg.

77.36K / 494.94K

Day Range

$0.98 - $1.09

52 Wk Range

0.77 - 3.18

Market Cap

$13.06M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

50

Short Interest

4.54%

Days to Cover

2.33

About

Sector

Health Care

Industry

Biotechnology

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hem...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry